Inventor · disambiguated record
Nathalie Silvestre
Also filed as: SILVESTRE NATHALIE
20 granted patents·6 pending applications·63 citations·filing 1995–2025
92Inventor score
Top patents by PatentIndex Score
26 records- 0188US10555981B2Oncolytic virus for expression of immune checkpoint modulatorsTRANSGENE SA·Filed 2015·Granted Feb 11, 2020·9 cites·15 claims
- 0286US10190105B2HBV polymerase mutantsTRANSGENE SA·Filed 2016·Granted Jan 29, 2019·5 cites·40 claims
- 0382US11779619B2Oncolytic virus for expression of immune checkpoint modulatorsTRANSGENE SA·Filed 2019·Granted Oct 10, 2023·1 cites·21 claims
- 0481US9512412B2HBV polymerase mutantsMARTIN PERRINE·Filed 2012·Granted Dec 6, 2016·6 cites·24 claims
- 0575US8420103B2Papillomavirus vaccinesBAUDIN MARTINE·Filed 2008·Granted Apr 16, 2013·8 cites·13 claims
- 0673US8513018B2Immortalized avian cell linesERBS PHILIPPE·Filed 2012·Granted Aug 20, 2013·1 cites·6 claims
- 0773US8357531B2Immortalized avian cell linesTRANSGENE SA·Filed 2010·Granted Jan 22, 2013·1 cites·6 claims
- 0869US8337859B2Vectors for multiple gene expressionSILVESTRE NATHALIE·Filed 2008·Granted Dec 25, 2012·3 cites·26 claims
- 0968US10662414B2Methods for treating or preventing HBV infection or HBV related diseasesTRANSGENE SA·Filed 2019·Granted May 26, 2020·0 cites·26 claims
- 1068US10076570B2Composition for treating HBV infectionMARTIN PERRINE·Filed 2012·Granted Sep 18, 2018·1 cites·14 claims
- 1165US9393299B2Composition for treating HBV infectionMARTIN PERRINE·Filed 2010·Granted Jul 19, 2016·1 cites·32 claims
- 1265US2023277639A1Personalized vaccineTRANSGENE·Filed 2023·Application pending·0 cites
- 1364US2025257135A1Novel antibodies and nucleotide sequences, and uses thereofBIOINVENT INT AB·Filed 2025·Application pending·0 cites
- 1461US8361788B2Immortalized avian cell lines comprising E1A nucleic acid sequencesTRANSGENE SA·Filed 2008·Granted Jan 29, 2013·0 cites·13 claims
- 1560US5834237ACombined use of two expression cassettes for the production of a protein of interestTRANSGENE SA·Filed 1995·Granted Nov 10, 1998·20 cites·34 claims
- 1658US10857226B2Composition for treating HBV infectionTRANSGENE SA·Filed 2018·Granted Dec 8, 2020·0 cites·22 claims
- 1756US11969462B2Personalized vaccineTRANSGENE·Filed 2018·Granted Apr 30, 2024·0 cites·18 claims
- 1855US9024003B2Avian telomerase reverse transcriptaseERBS PHILIPPE·Filed 2007·Granted May 5, 2015·0 cites·15 claims
- 1953US8809056B2Immortalized avian cell lines comprising E1A nucleic acid sequencesTRANSGENE SA·Filed 2012·Granted Aug 19, 2014·0 cites·16 claims
- 2047US2002172985A1Cassette for expressing a Toxoplasma gondii P30 proteinFiled 2001·Application pending·0 cites
- 2145US10765731B2Fusion of heterooligomeric mycobacterial antigensTRANSGENE SA·Filed 2015·Granted Sep 8, 2020·0 cites·23 claims
- 2243US2017072047A1Composition for Treating HBV InfectionTRANSGENE SA·Filed 2016·Application pending·0 cites
- 2341US2004038402A1Cassette increasing persistence of a transfected eukaryotic cell expressing a gene of interest, especially muscle cellFiled 2003·Application pending·0 cites
- 2440US6372443B1Cassette for expressing a toxoplasma gondii P30 proteinTRANSGENE SA·Filed 1995·Granted Apr 16, 2002·7 cites·8 claims
- 2539US2013095557A1Immortalized avian cell linesERBS PHILIPPE·Filed 2011·Application pending·0 cites
- 2633US10357555B2Mycobacterial antigen vaccineTRANSGENE SA·Filed 2013·Granted Jul 23, 2019·0 cites·16 claims
Join the waitlist — get patent alerts
Get an alert when Nathalie Silvestre files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →